SOCIETY ENDORSEMENT
COURSE DIRECTORS
Mack Mitchell, MD
Vice President for Medical Affairs
University of Texas Southwestern
Medical Center
Dallas, Texas
Lawrence Schiller, MD
Chair, Institutional Review Boards
Baylor University Medical Center
Dallas, Texas
FACULTY WILL BE ANNOUNCED SOON!
AGENDA
Friday, May 15, 2026
11:00 AM
Lunch and Registration
11:30 AM - 12:15 PM
Industry-Sponsored Event (Non-accredited)
Sponsored by Johnson & Johnson
​
12:15 PM - 12:45 PM
Break
12:45 PM - 1:00 PM
Program Overview
Session I
1:00 PM - 1:25 PM
Geriatrics in Gastroenterology ​
​
1:25 PM - 1:50 PM
Surveillance for Barrett’s Esophagus
Sachin Wani, MD
​​​​
1:50 PM - 2:15 PM
Management of Obesity in 2026​
2:15 PM - 2:30 PM
Q&A / Panel Discussion
2:30 PM – 2:45 PM
Break
Session II
​
2:45 PM - 3:10 PM
Reducing Alcohol Use in Patients with Steatotic Liver Disease
Jan Petrasek, MD
​
​​3:10 PM - 3:35 PM
NITs for Risk Stratification in Steatotic Liver Disease
Lisa VanWagner, MD
​​
3:35 PM - 4:00 PM
Updates in Primary Biliary Cholangitis
​​​​​
4:00 PM - 4:15 PM
Q&A / Panel Discussion
​
4:15 PM - 4:45 PM
Break
​​​​
4:45 PM - 5:30 PM
Industry-Sponsored Event (Non-accredited)
Sponsored by Ipsen Biopharmaceuticals
​
5:30 PM - 7:00 PM
Reception
​
Saturday, May 16, 2026
​
7:00 AM
Breakfast and Registration
​
7:30 AM - 8:15 AM
Industry-Sponsored Event (Non-accredited)
Sponsored by Eli Lilly and Co
​​​
8:15 AM – 8:45 AM
Break
8:45 AM - 8:50 AM
Program Overview
​
Session III
8:50 AM - 9:20 AM
What We Don’t Know About Celiac Disease
Lawrence Schiller, MD
9:20 AM - 9:50 AM
Endoscopic Challenges with GLP-1 Agonists
Harish Gagneja, MD
9:50 AM - 10:20 AM
Latest Updates in Irritable Bowel Syndrome (IBS)
Brooks Cash, MD
​​
​10:20 AM - 10:45 AM
Q&A / Panel Discussion
10:45 AM - 11:00 AM
Break
11:00 AM - 12:00 PM
Parallel Session (Select One)
-
GI Woes from Head to Toe
-
Inflammatory Bowel Disease
-
Obesity and Steatosis
-
Chronic Liver Disease
12:00 PM - 12:15 PM
Lunch Break
12:15 PM - 1:00 PM
Industry-Sponsored Event (Non-accredited)
Sponsored by Madrigal Pharmaceuticals
1:00 PM - 1:30 PM
Break
​
Session IV
1:30 PM - 2:00 PM
New and Emerging Treatments for the Management of Metabolic Dysfunction-Associated Steatohepatitis (MASH
​​
2:00 PM - 2:30 PM
Diagnosis and Management of Hereditary Alpha-1 Antitrypsin (A1AT) Deficiency
​
2:30 PM - 2:55 PM
Management of Complications of Portal Hypertension Including Hepatic Encephalopathy and Ascites
Kimberly Brown, MD
​
2:55 PM - 3:20 PM
Screening and Management of Hepatocellular Carcinoma
Sumeet Asrani, MD
3:20 PM - 3:35 PM
Q&A / Panel Discussion
3:35 PM - 3:45 PM
Break
Session V
3:45 PM - 4:15 PM
Positioning Therapies in Inflammatory Bowel Disease (IBD)
​​
4:15 PM - 4:45 PM
Managing the Pregnant Patient with IBD
4:45 PM - 5:15 PM
Preventative Care in IBD
Freddy Caldera, MD
5:15 PM - 5:30 PM
Q&A / Panel Discussion
5:30 PM - 5:40 PM
Meeting Wrap-up
